Tirzepatide is the active ingredient in Zepbound (FDA-approved for weight loss) and Mounjaro (FDA-approved for type 2 diabetes). If you’re searching for tirzepatide in Denver, you’re looking for one of those two brand-name medications — and Clinical Nutrition Center prescribes both.
Tirzepatide works differently from semaglutide (Wegovy, Ozempic). It activates both the GIP and GLP-1 receptors — a dual-agonist mechanism that has produced the largest average weight loss seen in any anti-obesity medication trial to date.
Tirzepatide in Denver: What You Should Know
Tirzepatide was first approved by the FDA in May 2022 as Mounjaro for type 2 diabetes. In November 2023, the FDA approved it as Zepbound for chronic weight management. The active molecule is identical — only the indication, dosing, and packaging differ.
Both medications require a prescription. At Clinical Nutrition Center, our physicians evaluate patients for tirzepatide therapy and prescribe either Zepbound or Mounjaro based on the indication. Most patients seeking weight loss are prescribed Zepbound.
The brand-name pricing for tirzepatide in Denver:
- Zepbound (weight loss): $299 for 2.5 mg, $399 for 5 mg, $449 for 7.5/10/12.5/15 mg doses
- Mounjaro (type 2 diabetes): similar dose-tier pricing, often covered by insurance for diabetes
- Insurance coverage: Many plans cover tirzepatide at $25/month with prior authorization. Our team handles PA paperwork for CNC patients.
Why Tirzepatide Produces More Weight Loss
Tirzepatide is a dual-agonist — it activates two incretin receptors simultaneously:
- GLP-1 receptor (the same mechanism as semaglutide / liraglutide): reduces appetite, slows gastric emptying, improves insulin response
- GIP receptor (glucose-dependent insulinotropic polypeptide): further enhances insulin sensitivity and may have additional effects on fat metabolism
The GIP component is what differentiates tirzepatide from semaglutide. In head-to-head trials (SURMOUNT-5), tirzepatide produced an average of 22% body weight loss versus 15% for semaglutide over 72 weeks — with the same rate of muscle preservation.
That extra 7 percentage points of weight loss is meaningful clinically. For a 230-pound patient, that’s roughly 16 additional pounds lost on tirzepatide compared to semaglutide.
Tirzepatide Prescribers Near Denver
Clinical Nutrition Center is a board-certified obesity medicine practice located in Greenwood Village, CO — about 12 miles south of downtown Denver. We serve patients across the Denver metro, including Highlands Ranch, Parker, Lone Tree, Centennial, Littleton, and Castle Rock.
Clinical Nutrition Center
5995 Greenwood Plaza Blvd #150
Greenwood Village, CO 80111
(303) 750-9454
Dr. Ethan Lazarus has been prescribing tirzepatide since its initial FDA approval in 2022 and has managed hundreds of patients on the medication. Our practice is in-network with most major insurance plans for office visits, and we provide prior authorization support for medication coverage.
Patients searching for tirzepatide in Denver typically have one of three goals:
- Weight loss: Zepbound is the FDA-approved brand. We prescribe and manage it.
- Type 2 diabetes with weight management: Mounjaro addresses both. Often covered by insurance.
- Switching from semaglutide (Wegovy / Ozempic) due to plateau or side effects: tirzepatide often produces better results.
See our dedicated Zepbound Denver page for weight-loss-specific information, dosing details, and pricing.
Tirzepatide vs. Semaglutide
If you’re deciding between tirzepatide (Zepbound) and semaglutide (Wegovy), here’s what the SURMOUNT-5 trial showed in head-to-head comparison:
| Outcome | Tirzepatide (Zepbound) | Semaglutide (Wegovy) |
|---|---|---|
| Average weight loss | ~22% | ~15% |
| Lean mass preservation | Same | Same |
| GI side effects | Comparable | Comparable |
| Cost (without insurance) | $299–$449/month | $199–$349/month |
| Insurance coverage | Improving | More established |
Neither medication is universally “better.” Tirzepatide produces greater average weight loss. Semaglutide is less expensive without insurance and has more established insurance coverage pathways. Our physicians help you decide based on your medical history, goals, and budget.
For a deeper dive on the SURMOUNT-5 data and muscle preservation outcomes, see our research breakdown.
Frequently Asked Questions — Tirzepatide Denver
Is tirzepatide the same as Zepbound?
Yes. Tirzepatide is the active molecule. Zepbound is the FDA-approved brand name for weight loss. Mounjaro is the FDA-approved brand name for type 2 diabetes. The active ingredient is identical.
Who prescribes tirzepatide in Denver?
Tirzepatide must be prescribed by a licensed provider. At Clinical Nutrition Center in Greenwood Village, our board-certified obesity medicine physicians prescribe tirzepatide (Zepbound or Mounjaro) for appropriate patients. We are about 12 miles south of downtown Denver.
How much does tirzepatide cost in Denver?
Without insurance, brand-name Zepbound costs $299/month at the starting 2.5 mg dose and up to $449/month at the highest maintenance doses. Many insurance plans cover tirzepatide at $25/month with prior authorization — see our Treatment Plans page for current pricing details.
Do I need diabetes to take tirzepatide?
No. Tirzepatide is FDA-approved for weight loss under the brand name Zepbound (with or without type 2 diabetes). It’s also FDA-approved for type 2 diabetes under the brand name Mounjaro. Our physicians evaluate each patient individually and prescribe the appropriate brand based on indication and coverage.
What are the side effects of tirzepatide?
Nausea, vomiting, constipation, diarrhea, and reduced appetite are the most common — usually mild and dose-dependent. We start at low doses (2.5 mg) to minimize side effects and titrate up gradually. Most patients tolerate tirzepatide well after the first 4-6 weeks.
How long do patients stay on tirzepatide?
Most patients stay on long-term. Weight regain is common if the medication is stopped abruptly. We work with you to make a plan that fits your life and goals.
Can I switch from semaglutide to tirzepatide?
Yes. Many patients switch due to plateau, side effects, or to get better results. The transition is managed by our physicians — typically with a washout period and re-titration from a low tirzepatide dose.
Do you offer compounded tirzepatide?
No. The FDA no longer allows sales of compounded tirzepatide from 503B pharmacies. We prescribe only FDA-approved brand-name tirzepatide (Zepbound or Mounjaro).
Ready to Start Tirzepatide?
Clinical Nutrition Center
5995 Greenwood Plaza Blvd #150
Greenwood Village, CO 80111
(303) 750-9454
Schedule Your Free Preview Visit ›
Dr. Ethan Lazarus is a board-certified obesity medicine physician and the clinical director of Clinical Nutrition Center in Greenwood Village, Colorado, with over 22 years of experience helping patients achieve lasting metabolic health.